Navigation Links
Spiral Flow[TM] Grafts Offer Superior Clinical Outcomes in Prosthetic Bypass Grafting
Date:11/20/2012

DUNDEE, Scotland, November 20, 2012 /PRNewswire/ --

Mr Shaper FRCS, Consultant Vascular Surgeon at Bradford Royal Infirmary, said, "The study showed significantly encouraging initial results for the use of Spiral Laminar Flow[TM] grafts in lower extremity bypasses to warrant continued usage and further long term data acquisition."

Initial results, from the on-going study, were presented at the 39th Annual Veith Symposium on Friday 16th November, 2012 in New York, USA. The study followed up the implantation of 31 Spiral Flow[TM] peripheral vascular grafts (Vascular Flow Technologies, Dundee, UK) between February 2011 to October 2012 with prospective data on-going and a retrospective analysis of 136 conventional ePTFE grafts  from same unit implanted between January 2003 to December 2008. The comparison presented was based on 1 year data available on 114 conventional PTFE grafts and 12 SLF[TM] grafts. The patients all had lower extremity bypasses.

     (Photo: http://photos.prnewswire.com/prnh/20121120/577588 )

The study showed that primary patency for the SLF[TM] graft was 92% compared to 48% for the conventional PTFE graft and secondary patency 100% for the SLF[TM] graft compared to 55% for the conventional PTFE graft. The amputation rate in the SLF[TM] graft group was 0% compared to 10% for the conventional graft group.

The innovative design of the Spiral Flow[TM] Graft is different from all other prosthetic vascular grafts. Near the distal end of the graft there is a 'Spiral Flow Inducer'- an ePTFE helical ridge on the graft lumen which remodels turbulent blood flow created by diseased vessels and conventional grafts into the body's own natural spiral flow pattern.

Neointimal hyperplasia (NIH) is the primary cause of failure in prosthetic grafts. It is caused, to a large degree, by turbulent blood flow - the Spiral Flow[TM] Graft re-instates natural blood flow thereby eliminating turbulence as a cause of NIH.

For more information:
Call: +44(0)1382-598-532 E-mail: news@vascular-flow.com Visit: http://www.vascular-flow.com

For more press information contact:
Bill Allan: +44(0)7920-143-030
Caroline Thoms: +44(0)1382-598-532



'/>"/>
SOURCE Vascular Flow Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Two Top Notch Cadaver Workshops Offered by joimax® in April
3. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
4. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
5. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
6. Cochlear™ Americas Adds the Nucleus® Support App to its Mobile Service Offerings
7. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
8. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
9. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
10. Boston Scientific and Philips Healthcare Announce Collaboration to Enhance Imaging Equipment Offering
11. San Diego Based Neurosurgeon Offers Groundbreaking Treatment to Restore Function for People Suffering from Mobility Inhibiting Paralysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... --Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today the start ... hands-on learning experience is a 12-week summer program, May ... and Internship programs bring participants to ... are provided optional housing free of charge through Diplomat ... Riverfront Residence Hall to foster communication and collaboration among ...
(Date:5/23/2016)... , May 23, 2016 ... Market Size, Share, Development, Growth and Demand Forecast ... Single and Other), by Application (Drug Discovery and ... End Users (Pharmaceuticals, Life Science and Biotechnology, Academic ... P&S Market Research, the global mass spectrometry ...
(Date:5/23/2016)... 2016 The World Health Organization (WHO) expanded the ... include adolescents aged 13 years, and above. Effective immediately, the ... adult and adolescent males in the 14 priority countries in ... the first male circumcision device to receive WHO Prequalification on ... Horowitz said: " The expanded use of ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... ... managed services today announced a strategic partnership with Five9 (Nasdaq: FIVN), a ... Altura, one of Avaya’s largest Platinum Business Partners, is a leading provider ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... Center at Sentara Northern Virginia Medical Center located in Woodbridge, VA. The ... surgical services into a single site. , The new 2 story building houses ...
(Date:5/24/2016)... ... May 24, 2016 , ... New Brunswick, New Jersey: This year marks Children’s ... fullest potential. To commemorate the anniversary, the hospital has themed the milestone “Hats Off” ... Children’s Specialized Hospital Foundation on Saturday, May 21, at Johnson Park in Piscataway, New ...
(Date:5/24/2016)... Bahama (PRWEB) , ... May 24, 2016 , ... Regenerative ... Such breakthroughs in adult stem cell therapy technology, protocols and patient results as have ... emerging field to become a more accessible standard of care for patients worldwide. , ...
(Date:5/24/2016)... ... , ... Loma Linda University Health (LLUH) has officially broken ground on the ... 3,000 people looked on as the shovels hit the dirt at the community groundbreaking ... During the program, Richard H. Hart, MD, DrPH, president, LLUH, recapped the history of ...
Breaking Medicine News(10 mins):